Eye drop study tracks healing for rare corneal disease over 2.5 years
NCT ID NCT05552261
Summary
This study followed 24 patients with a rare eye condition called neurotrophic keratitis to see if the benefits of a prescription eye drop (OXERVATE) lasted long-term. Patients had previously received up to 8 weeks of treatment and were then monitored for 30 months to check if their corneal healing was maintained and to assess long-term safety. The study also measured changes in vision, eye sensitivity, tear production, and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROTROPHIC KERATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cincinnati Eye Institute
Edgewood, Kentucky, 41017, United States
-
New Vision Institute
San Diego, California, 92037, United States
-
Scheie Eye Institute
Philadelphia, Pennsylvania, 19104, United States
-
Tufts Medical Center
Boston, Massachusetts, 02011, United States
Conditions
Explore the condition pages connected to this study.